231 related articles for article (PubMed ID: 2553899)
1. Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors.
Johnston CI; Fabris B; Yamada H; Mendelsohn FA; Cubela R; Sivell D; Jackson B
J Hypertens Suppl; 1989 Sep; 7(5):S11-6. PubMed ID: 2553899
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors.
Johnston CI; Mendelsohn FA; Cubela RB; Jackson B; Kohzuki M; Fabris B
J Hypertens Suppl; 1988 Dec; 6(3):S17-22. PubMed ID: 2852234
[TBL] [Abstract][Full Text] [Related]
3. Effects of perindopril on angiotensin converting enzyme in tissues of the rat.
Jackson B; Cubela RB; Johnston CI
J Hypertens Suppl; 1988 Dec; 6(3):S51-4. PubMed ID: 2852236
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats.
Fabris B; Yamada H; Cubela R; Jackson B; Mendelsohn FA; Johnston CI
Br J Pharmacol; 1990 Jul; 100(3):651-5. PubMed ID: 2167741
[TBL] [Abstract][Full Text] [Related]
5. Effects of idrapril calcium on tissue angiotensin-converting enzyme in rats.
Becagli P; Lippi A; Criscuoli M; Breschi MC; Subissi A
J Cardiovasc Pharmacol; 1995 Jul; 26(1):27-32. PubMed ID: 7564361
[TBL] [Abstract][Full Text] [Related]
6. High affinity binding sites for Perindopril a new inhibitor of angiotensin-I-converting enzyme (ACE) in the rabbit kidney: possible evidence for localization of ACE in endothelial structures and in glomerular mesangium.
Morin JP; Moulin B; Borghi H; Fillastre JP
Int J Tissue React; 1989; 11(2):81-92. PubMed ID: 2559047
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition: prospects for the future.
Jackson B; Mendelsohn FA; Johnston CI
J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S4-8. PubMed ID: 1725200
[TBL] [Abstract][Full Text] [Related]
8. Characterization of angiotensin converting enzyme (ACE) in the testis and assessment of the in vivo effects of the ACE inhibitor perindopril.
Jackson B; Cubela RB; Sakaguchi K; Johnston CI
Endocrinology; 1988 Jul; 123(1):50-5. PubMed ID: 2838262
[TBL] [Abstract][Full Text] [Related]
9. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
Perich RB; Jackson B; Rogerson F; Mendelsohn FA; Paxton D; Johnston CI
Mol Pharmacol; 1992 Aug; 42(2):286-93. PubMed ID: 1325031
[TBL] [Abstract][Full Text] [Related]
10. ACE inhibitors: future perspectives.
Reid JL
J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S41-3. PubMed ID: 7507539
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
Udupa EG; Rao NM
Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II.
Sun Y; Ratajska A; Weber KT
J Lab Clin Med; 1995 Jul; 126(1):95-101. PubMed ID: 7602241
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme in the rat heart: studies of its inhibition in vitro and ex vivo.
Fabris B; Jackson B; Cubela R; Mendelsohn FA; Johnston CI
Clin Exp Pharmacol Physiol; 1989 Apr; 16(4):309-13. PubMed ID: 2545394
[TBL] [Abstract][Full Text] [Related]
15. Tissue distribution of angiotensin converting enzyme and its inhibition by perindopril in pregnant rabbit and fetus.
Moulin B; Morin JP; Seurin-Toutain P; Borghi H; Fillastre JP
Int J Tissue React; 1990; 12(5):309-17. PubMed ID: 1967131
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tissue angiotensin converting enzyme by perindopril: in vivo assessment in the rat using radioinhibitor binding displacement.
Jackson B; Cubela RB; Johnston CI
J Pharmacol Exp Ther; 1988 Jun; 245(3):950-5. PubMed ID: 2838609
[TBL] [Abstract][Full Text] [Related]
17. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA
Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432
[TBL] [Abstract][Full Text] [Related]
18. [Ramipril and cardiac and renal angiotensin converting enzyme].
Grima M; Stephan D; Welsch C; Coquard C; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():43-8. PubMed ID: 7646311
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic effects of angiotensin-converting enzyme inhibitors on tissue angiotensin-converting enzyme.
Chai SY; Perich R; Jackson B; Mendelsohn FA; Johnston CI
Clin Exp Pharmacol Physiol Suppl; 1992; 19():7-12. PubMed ID: 1327597
[TBL] [Abstract][Full Text] [Related]
20. Plasma renin activity and changes in tissue angiotensin converting enzyme.
Michel B; Grima M; Stephan D; Coquard C; Welsch C; Barthelmebs M; Imbs JL
J Hypertens; 1994 May; 12(5):577-84. PubMed ID: 7930558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
